HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline.

Abstract
N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a natural inhibitor of pluripotent hematopoietic stem cell proliferation and is normally found in human plasma. Because AcSDKP is hydrolyzed by the N-terminal active site of angiotensin converting enzyme and partially eliminated in urine, its plasma level is a result of a complex balance between its production, hydrolysis by ACE, and renal elimination. In this study, we attempted to establish an enzyme immunoassay (EIA) for quantifying AcSDKP-like immunoreactive substance (IS), which is applicable for monitoring plasma AcSDKP levels in healthy subjects and patients with chronic renal failure. Using β-D-galactosidase-labeled Gly-γAbu-SDKP as a marker antigen, an anti-rabbit IgG-coated immunoplate as a bound/free separator and 4-methylumbelliferyl-β-D-galactopyranoside as a fluorogenic substrate, a highly sensitive and specific EIA was developed for the quantification of AcSDKP-IS in human plasma. The lower limit of quantification was 0.32 fmol/well, and the sharp inhibition competitive EIA calibration curve obtained was linear between 8.0 and 513 fmol/ml. This EIA was so sensitive that only 10 µl plasma sample was required for a single assay. The coefficients of variation (reproducibility) for human plasma concentrations of 0.2 and 2.1 pmol/ml were 7.2 and 7.7%, respectively, for inter-assay and 13.3 and 7.8% for intra-assay comparisons. Plasma AcSDKP-IS level was significantly higher in patients with chronic renal failure (0.92 ± 0.39 pmol/ml) compared with healthy subjects (0.29 ± 0.07 pmol/ml). These results suggest that our EIA may be useful to evaluate plasma AcSDKP level as a biomarker in various patients.
AuthorsYosuke Suzuki, Hiroki Itoh, Fumihiko Katagiri, Fuminori Sato, Kanako Kawasaki, Yuhki Sato, Hiromitsu Mimata, Masaharu Takeyama
JournalJournal of peptide science : an official publication of the European Peptide Society (J Pept Sci) Vol. 18 Issue 4 Pg. 276-81 (Apr 2012) ISSN: 1099-1387 [Electronic] England
PMID22396066 (Publication Type: Journal Article)
CopyrightCopyright © 2012 European Peptide Society and John Wiley & Sons, Ltd.
Chemical References
  • Anticoagulants
  • Biomarkers
  • Immune Sera
  • Oligopeptides
  • Heparin
  • Edetic Acid
  • beta-Galactosidase
  • goralatide
Topics
  • Adult
  • Aged
  • Antibody Specificity
  • Anticoagulants (chemistry)
  • Biomarkers (blood)
  • Calibration
  • Case-Control Studies
  • Circadian Rhythm
  • Edetic Acid (chemistry)
  • Female
  • Heparin (chemistry)
  • Humans
  • Immune Sera
  • Immunoenzyme Techniques (methods, standards)
  • Male
  • Middle Aged
  • Oligopeptides (blood, immunology)
  • Protein Stability
  • Reference Standards
  • Renal Insufficiency, Chronic (blood)
  • Sensitivity and Specificity
  • beta-Galactosidase

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: